THERAVANCE BIOPHARMA R&D IP, LLC et al v. ACCORD HEALTHCARE, INC. et al
| THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED and MYLAN SPECIALTY L.P. |
| ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD. and INTAS PHARMACEUTICALS LTD. |
| 1:2023cv00157 |
| February 17, 2023 |
| US District Court for the Middle District of North Carolina |
| WILLIAM L OSTEEN |
| JOI ELIZABETH PEAKE |
| Patent - Abbreviated New Drug Application(ANDA) |
| 28 U.S.C. ยง 1338 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 28, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 NOTICE of Voluntary Dismissal of case by Plaintiffs MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. (MORROW, JOHN) |
| Case ASSIGNED to JUDGE WILLIAM L. OSTEEN, JR and MAG/JUDGE JOI ELIZABETH PEAKE. (Bowers, Alexis) |
| CASE REFERRED to Mediation pursuant to Local Rule 83.9b of the Rules of Practice and Procedure of this Court. Please go to our website under Attorney Information for a list of mediators which must be served on all parties. (Bowers, Alexis) |
| Filing 5 Corporate Disclosure Statement identifying Corporate Parent Viatris Inc. for MYLAN IRELAND LIMITED.. (DUBIS, MELANIE) |
| Filing 4 Corporate Disclosure Statement identifying Corporate Parent Viatris Inc. for MYLAN SPECIALTY L.P... (DUBIS, MELANIE) |
| Filing 3 NOTICE of Attorney Appearance by attorney MELANIE BLACK DUBIS on behalf of Plaintiffs MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P. (DUBIS, MELANIE) |
| Filing 2 Corporate Disclosure Statement identifying Corporate Parent THERAVANCE BIOPHARMA R&D IP, LLC for THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC... (MORROW, JOHN) |
| Filing 1 COMPLAINT for Patent Infringement against All Defendants ( Filing fee $ 402 receipt number ANCMDC-3498360.), filed by THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA US, INC., MYLAN IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, MYLAN SPECIALTY L.P.. (Attachments: #1 Exhibit A - US 8541451, #2 Exhibit B - US 9765028, #3 Exhibit C - US 10550081, #4 Exhibit D - US 11008289, #5 Exhibit E - US 11484531, #6 Exhibit F - YUPELRI PI (05.2022))(MORROW, JOHN) Modified on 2/17/2023 to complete caption title. (Bowers, Alexis). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the North Carolina Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
